1887

Abstract

The cycle threshold (Ct) value in real-time PCR (RT-PCR) is where a target-specific amplification signal becomes detectable and can infer viral load, risk of transmission and recovery. Use of Ct values in routine practice is uncommon.

There is a lack of routine use of Ct values when reporting RT-PCR results in routine practice.

To automatically insert Ct values and interpretive comments when reporting SARS-CoV-2 RT-PCR to improve patient management.

Routine Ct values across three different RT-PCR platforms were reviewed for concordance at presentation and clearance in patients with COVID-19. An indicative threshold (IT) linked to viral clearance kinetics was defined at Ct30 to categorize Ct values as low and high, reflecting high and low viral loads respectively.

The different gene targets of each platform showed high correlation and kappa score agreement (<0.001). Average Ct values were automatically generated with values ≤Ct30 reported as positive and >Ct30 as reactive; interpretive comments were added to all reports. The new reporting algorithm impacted on: physician interpretation of SARS-CoV-2 results; patient management and transfer; staff surveillance; length of stay in quarantine; and redefinition of patient recovery.

Incorporation of Ct values into routine practice is possible across different RT-PCR platforms and adds useful information for patient management. The use of an IT with interpretive comments improves clinical interpretation and could be a model for reporting other respiratory infections. Withholding Ct values wastes useful clinical data and should be reviewed by the profession, accreditation bodies and regulators.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001499
2022-05-16
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/71/5/jmm001499.html?itemId=/content/journal/jmm/10.1099/jmm.0.001499&mimeType=html&fmt=ahah

References

  1. World Health Organization Timeline of WHO’s response to COVID-19; 2022 https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline
  2. World Health Organization Laboratory Testing of 2019 Novel Coronavirus (2019-nCoV) in Suspected Human Cases: Interim Guidance Geneva: World Health Organization; 2020
    [Google Scholar]
  3. Li R, Pei S, Chen B, Song Y, Zhang T et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science 2020; 368:489–493 [View Article] [PubMed]
    [Google Scholar]
  4. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med 2020; 172:577–582 [View Article] [PubMed]
    [Google Scholar]
  5. World Health Organization Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19); 2020 https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf accessed 10 March 2020
  6. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med 2020; 382:970–971 [View Article] [PubMed]
    [Google Scholar]
  7. Zou L, Ruan F, Huang M, Liang L, Huang H et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 382:1177–1179 [View Article] [PubMed]
    [Google Scholar]
  8. He X, Lau EHY, Wu P, Deng X, Wang J et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 2020; 26:672–675 [View Article] [PubMed]
    [Google Scholar]
  9. Ganyani T, Kremer C, Chen D, Torneri A, Faes C et al. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Euro Surveill 2020; 25:17 [View Article]
    [Google Scholar]
  10. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020; 581:465–469 [View Article] [PubMed]
    [Google Scholar]
  11. Bullard J, Dust K, Funk D, Strong JE, Alexander D et al. Predicting Infectious SARS-cov-2 from Diagnostic Samples 2020 [View Article]
    [Google Scholar]
  12. La Scola B, Le Bideau M, Andreani J, Hoang VT, Grimaldier C et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis 2020; 39:1059–1061 [View Article] [PubMed]
    [Google Scholar]
  13. Wishaupt JO, Ploeg T van der, Smeets LC, Groot R de, Versteegh FGA et al. Pitfalls in interpretation of CT-values of RT-PCR in children with acute respiratory tract infections. J Clin Virol 2017; 90:1–6 [View Article] [PubMed]
    [Google Scholar]
  14. Spencer S, Chung J, Thompson M, Piedra PA, Jewell A et al. Factors associated with real-time RT-PCR cycle threshold values among medically attended influenza episodes. J Med Virol 2016; 88:719–723 [View Article] [PubMed]
    [Google Scholar]
  15. Curran T, Coyle PV. Understanding the true burden and infection dynamics of Bordetella pertussis using molecular diagnostics. J Infect 2016; 72:504–505 [View Article] [PubMed]
    [Google Scholar]
  16. Centers for Disease Control and Prevention: Duration of Isolation and Precautions for Adults with COVID-19; 2020 https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html accessed 19 October 2020
  17. van Kampen JJA, van de Vijver D, Fraaij PLA, Haagmans BL, Lamers MM et al. Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants. Infectious Diseases (except HIV/AIDS) 2020 [View Article]
    [Google Scholar]
  18. Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa. Clin Infect Dis 2019; 68:895–902 [View Article] [PubMed]
    [Google Scholar]
  19. Sethuraman N, Jeremiah SS, Ryo A. Interpreting diagnostic tests for SARS-CoV-2. JAMA 2020; 323:2249–2251 [View Article] [PubMed]
    [Google Scholar]
  20. Wajnberg A, Mansour M, Leven E, Bouvier NM, Patel G et al. Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-cov 2 patients in the new york city region. medRxiv 2020
    [Google Scholar]
  21. Public Health England Cycle threshold (Ct) in SARS-CoV-2 RT-PCR: A guide for health protection teams about interpreting Ct in real-time, reverse transcription polymerase chain reaction (RT-PCR) assays performed for SARS-CoV-2; 2020 https://www.gov.uk/government/publications/cycle-threshold-ct-in-sars-cov-2-rt-pcr accessed 28 October 2020
  22. Korea Disease Control and Prevention Agency Findings from investigation and analysis of re-positive cases. In: Korea Disease Control and Prevention Agency; 2020 http://www.kdca.go.kr/board/board.es?mid=a30402000000&bid=30402000030 accessed 19 May 2020
  23. Tian D, Lin Z, Kriner EM, Esneault DJ, Tran J et al. Ct values do not predict severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmissibility in college students. J Mol Diagn 2021; 23:1078–1084 [View Article] [PubMed]
    [Google Scholar]
  24. Yang Q, Saldi TK, Gonzales PK, Lasda E, Decker CJ et al. Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities. Proc Natl Acad Sci U S A 2021; 118:21 [View Article] [PubMed]
    [Google Scholar]
  25. Peto T. UK COVID-19 Lateral Flow Oversight Team COVID-19: rapid antigen detection for SARS-cov-2 by lateral flow assay: a national systematic evaluation for mass-testing. medRxiv 2021 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.001499
Loading
/content/journal/jmm/10.1099/jmm.0.001499
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error